CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants [Phase 2]

Results from a Phase 2 study of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccination regimen in infants have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Janssen Vaccines & Prevention B.V. | Conditions: Ebola Virus Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-06-22